[Anti-arrhythmia effectiveness of phosphobion and finoptin in the treatment of atrioventricular retrograde paroxysmal tachycardia].
Forty-four cases of induced atrioventricular retrograde paroxysmal tachycardia (AVRPT) were studied. AVRPT was provoked by means of frequent esophageal stimulation of the left atrium. During the study, records from the external and esophageal ECG leads were taken. Administration of 10 mg finoptin controlled the AVRPT attack in 86.7% of cases, and the administration of 10 mg fosfobion, in 76.2%. Antegrade block of echo impulse conduction through the atrioventricular node was the electrophysiologic mechanism of AVRPT control in all cases. The time needed to control the attack by the above-mentioned drugs ranged from a few seconds to 5 minutes. Changes of atrioventricular conductivity and patients' subjective sensations were more marked where fosfobion was used.
Lukoshiavichiute
A I
AI
Gedrimene
D A
DA
D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D000293:Adolescent; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013611:Tachycardia, Atrioventricular Nodal Reentry / Q000188:drug therapy*; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy*; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*; D014700:Verapamil / Q000627:therapeutic use*
D000255:Adenosine Triphosphate; D014700:Verapamil
Protivoaritmicheskaia éffektivnos't fosfobiona i finoptina v kupirovanii pristupa atrioventrikuliarnoĭ vozvratnoĭ paroxizma'lnoĭ takhikardii.